DiaCarta, Ltd., in Pleasnton, CA, a novel molecular diagnostic test developer for cancer and infectious diseases, today announced that it has received accreditation by the College of American Pathologists (CAP) for its CLIA certified lab. "This CAP Accreditation is a tremendous accomplishment that signifies DiaCarta’s commitment to excellence and I am proud of our team’s dedication in support this major milestone," said Zheng Li, Vice President of Medical Clinical Affairs at DiaCarta.
For the full article click here: DiaCarta Receives Accreditation by the College of American Pathologists (CAP)
